Cooper Profit Margin 2006-2019 | COO
Current and historical gross margin, operating margin and net profit margin for Cooper (COO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cooper net profit margin as of January 31, 2019 is 14.22%.
| Cooper Annual Profit Margins |
|---|
| Cooper Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.885B | $2.533B |
| The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Becton Dickinson (BDX) | United States | $61.317B | 20.37 |
| Align Technology (ALGN) | United States | $22.518B | 57.33 |
| McKesson (MCK) | United States | $21.887B | 8.52 |
| AmerisourceBergen (ABC) | United States | $15.293B | 11.10 |
| Laboratory Of America Holdings (LH) | United States | $14.330B | 13.18 |
| Cardinal Health (CAH) | United States | $13.709B | 9.24 |
| DENTSPLY SIRONA (XRAY) | United States | $11.127B | 24.74 |
| Henry Schein (HSIC) | United States | $9.192B | 14.85 |
| West Pharmaceutical Services (WST) | United States | $8.223B | 39.69 |
| Merit Medical Systems (MMSI) | United States | $3.170B | 34.12 |
| CONMED (CNMD) | United States | $2.242B | 36.43 |
| Patterson (PDCO) | United States | $2.031B | 16.05 |
| Atrion (ATRI) | United States | $1.612B | 47.31 |
| STAAR Surgical (STAA) | United States | $1.380B | 115.59 |
| Antares Pharma (ATRS) | United States | $0.437B | 0.00 |
| Invacare (IVC) | United States | $0.222B | 0.00 |
| Lifevantage (LFVN) | United States | $0.158B | 21.27 |
| Pro-Dex (PDEX) | United States | $0.063B | 28.64 |
| Endologix (ELGX) | United States | $0.060B | 0.00 |
| Biolase (BIOL) | United States | $0.049B | 0.00 |
| Retractable Technologies (RVP) | United States | $0.023B | 0.00 |
| Milestone Scientific (MLSS) | United States | $0.015B | 0.00 |
